Abivax SA is positioning to change the treatment landscape in ulcerative colitis after delivering positive results and a favorable safety profile in two phase III trials of its orally available ...

Dispatch Biotherapeutics Inc. is taking aim at solid tumors with a new viral vector/antigen technology backed by major industry names such as Arch Venture Partners and Bristol Myers Squibb Co. With ...

In order to enhance the conversion efficiency of dual-active-bridge converters, a hybrid five-variable (HFV) modulation strategy with the aid of deep reinforcement learning technique is proposed in ...

We fabricate an O-band membrane InGaAlAs electro-absorption modulator (EAM) integrated with a III-V/Si DFB laser on a Si photonics platform. The device exhibits 6-mW fibre-coupled output power through ...